Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention
RecruitingHealthy volunteers welcome
Who can join
Ages 15 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Self-identifies as a cisgender man, transgender man (assigned female at birth, trans-masculine spectrum), or transgender woman (assigned male sex at birth, trans-feminine spectrum) * Report sex with a cisgender man or transgender woman or any individual assigned male sex at birth in the past 12 months * Age 15 years or older * Willing and able to provide written informed consent * Owns an iOS or Android mobile phone and able to access the internet and send and receive text messages * Able to understand, read, and speak English or Spanish * Newly initiated PrEP or currently on PrEP and at risk for PrEP discontinuation based on at least one of the following: * Initiated PrEP within the past 6 months, or * Has any of the following risk factors for PrEP discontinuation: missed clinic visits; age \< 30; African-American or Latino; transgender gender identity; or self-reported illicit substance use Exclusion Criteria: * Currently enrolled in another PrEP intervention study * Unable to complete 12 month study participation * Any medical, psychiatric, or social condition or other responsibilities that, in the judgment of the investigator, would make participation in the study unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.
About the study
The purpose of this study is to compare the effectiveness of two mobile health technologies (text messaging or a mobile app) designed to help people take HIV pre-exposure prophylaxis (PrEP) as directed by the clinic. PrEP is the use of a daily anti-HIV medications by HIV-negative people to help prevent HIV infection.
What is being tested
- PrEPmate (other)
- Dot Diary (device)
Sponsor: Public Health Foundation Enterprises, Inc. · Participants: 300 · Started: Jul 21, 2021
Contact the study team
Official record on ClinicalTrials.gov — NCT04855773
Locations in the U.S.
| California | San Francisco AIDS Foundation, San Francisco |
| District of Columbia | Whitman-Walker Health, Washington D.C. |
| Florida | University of Miami, Miami |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.